Bharat Bio's nasal Covid vaccine gets regulator nod for phase 3 trials

India's drug regulator has given permission to Bharat Biotech to conduct phase-3 clinical trial for its intranasal Covid vaccine as booster dose on participants who have been previously inoculated......

Bharat Biotech completes phase-III trials for nasal Covid vaccine

Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe. Photograph:......

India's 1st Covid nasal vax gets phase 2 trial nod

The first nasal vaccine against COVID-19, developed by Bharat Biotech, has received regulator's nod for conducting phase 2 clinical trials, the Department of Biotechnology said on Friday. Phase 1......

Nasal Covid Vaccine Available In Jan

The vaccine would not have production scalability issues unlike Covaxin, Bharat Biotech's COVID-19 virus vaccine. IMAGE: Kindly note the image has only been posted for representational purposes........